Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

John Dormandy, Bernard H. Charbonnel, D.J.A. Eckland et al. · The Lancet · 2005

Cited by 4,140 works. doi:10.1016/s0140-6736(05)67528-9

Authors

References